One of the big mysteries with popular GLP-1 medications for weight loss is why some people will lose 20% or more of their starting body weight on the drugs while for others, the scale will barely ...
A new drug to control liver disease has gotten the green light. The U.S. Food and Drug Administration (FDA) has approved the French drugmaker Ipsen’s medication Iqirvo (elafibranor). The drug, an 80 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback